| Tap a line for its trend | FY25Mar 2025 | FY24Mar 2024 |
|---|
| 188.96× | 0.00× | |
| 39,384.05× | — | |
| 0.00× | 0.01× | |
| 0.26× | 0.20× | |
| 0.30× | 1.08× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | |
|---|---|---|---|
| Receivable Days (DSO) | 0.00 | 188.96 | |
| Payable Days (DPO) | — | 39,384.05 | |
| Asset Turnover | 0.01 | 0.00 | |
| Cash Conversion (CFO/Net Income) | 0.20 | 0.26 | |
| CFO/EBITDA | 1.08 | 0.30 |